The combination of dairy protein and dietary calcium (Ca) may enhance weight loss more effectively than either compound alone. Our purpose in this study was to determine the effect of various protein sources [skim milk powder (SMP), whey, casein, and soy protein isolate (SPI)] and 2 levels of Ca [low, 0.67% Ca (LC) or high, 2.4% Ca (HC)] on weight loss. Sixtyfour 12-wk-old Sprague-Dawley, diet-induced obese rats were assigned to 1 of 8 energy-restricted (ER) diets for 4 wk with 1 of the 4 protein sources and either LC or HC concentrations. Rats were ER to 70% of the ad libitum food and energy intake of a reference group (n = 8) fed the AIN-93M diet. The interaction between dietary protein and Ca affected final body weight and fat mass (FM) (P , 0.05). FM was less in rats fed SMP-HC than in those fed casein-LC or SPI-LC. Lean body mass was greater in rats fed SMP than in those fed whey. Rats fed HC diets had a lower plasma glucagon area under the curve (AUC) than those fed LC diets. The blood glucose AUC, homeostatic model of insulin resistance, and the expression of certain hepatic genes involved in energy metabolism were affected by protein and Ca. These data suggest that consuming a diet containing SMP and HC is associated with a lower FM in obese, male, ER rats than in diets containing casein or SPI and LC; however, the role of SMP and Ca in glucose homeostasis remains to be determined.
Introduction
Dairy foods are characterized by high quality protein, a rich micronutrient base, and a variety of bioactive compounds (1) . Several studies have reported a positive role of dairy foods in the management of obesity and its related comorbidities. The NHANES III found that those individuals with the highest calcium (Ca) intake had an 85% lower chance of being in the highest quartile for BMI (2) . Moreover, several randomized clinical trials (3, 4) , although not all (5, 6) , have reported that dietary Ca and dairy foods accelerate fat loss during energy restriction. In studies that reported favorable metabolic effects of dairy products and Ca consumption, participants were overweight or obese, had habitually low Ca intake, and were energy-restricted (ER) 5 during the study (7) . Although many observational and experimental studies have shown a positive association between dairy foods and weight management, the topic remains controversial, with studies showing beneficial effects and a similar number showing no effects (7) (8) (9) . The specific factors in dairy foods that could promote weight loss are not known, although the protein and amino acid (AA) compositions, and Ca concentrations have been postulated to play a role. Many questions are also unanswered regarding the mechanisms through which dairy food and Ca intake influence weight control. Although previ-ously thought to play a major role in the regulation of body weight, Ca alone does not appear to have the same degree of weight regulatory effects as dairy foods and it likely acts with other bioactive components found in milk-derived products (10) .
The protein in dairy foods consists of ;80% casein and ;20% whey. We have previously demonstrated that casein, whey, and skim milk powder (SMP) have differential effects on weight gain in obese rats that consumed ad libitum high-fat, high-sucrose diets (HFHS), with SMP attenuating weight gain significantly more than whey or casein alone (11) . Whether the individual protein fractions of dairy foods (casein and whey) also have distinct effects on weight loss remains to be determined. Our primary objectives, therefore, were to determine the difference among diets in which protein is derived from various sources [SMP, casein, whey, and soy protein isolate (SPI)] on the promotion of weight loss in obese rats and to determine whether a high-Ca diet (HC) alters weight loss in the same rat model. Our secondary objectives were to examine metabolic biomarkers and gene expression related to glucose homeostasis.
Materials and Methods
Animals, housing, and diets. The experimental protocol was approved by the University of Calgary Animal Care Committee and conformed to the Guide for the Care and Use of Laboratory Animals. Six-week-old male, Sprague-Dawley rats (n = 144) were obtained from Charles River and maintained on a 12-h-light/-dark cycle in a temperature-and humidity-controlled room. For 6 wk, rats consumed a HFHS diet ad libitum to induce obesity (Table 1) . At 12 wk of age, the rats (n = 72) in the upper 50th percentile of body weight were selected as the dietinduced obese (DIO) rats (12) and then individually housed for the remainder of the study.
Experimental diets. Obese rats were divided into 9 weight-matched groups (n = 8), which included 8 ER groups of rats and 1 reference group that consumed AIN-93M diet ad libitum to define normal food and energy intakes and weight gain. The diets varied in protein source (SMP, casein, whey, or SPI). Casein and whey were selected as protein sources, because they are the major protein fractions of SMP, making up 80% and 20% of its protein content, respectively. In addition to the milk proteins (SMP, casein, and whey), SPI was also utilized. Soy protein is a plant protein of equal protein quality to milk and has previously been reported as being effective for reducing body weight (13) . No other study to our knowledge has directly examined the effectiveness of SPI compared with the various milk proteins during energy restriction in obese rats.
All diets had 12% of total energy derived from protein. To ensure the nitrogen content of each diet was matched, diets containing SMP had more added compared with the casein, whey, or SPI powders (Table 1) . This adjustment compensated for the lower protein content of SMP compared with the other protein sources. All diets were mixed in-house and were designed to meet the nutritional requirements of adult rats with amounts of L-cystine, AIN-93M vitamin mix, AIN-93M mineral mix, acellulose, and choline bitartrate consistent with the AIN-93M diet (14) . The reference rats consumed the AIN-93M diet (14) ad libitum to provide a value for normal, nonrestricted food intake.
Diets also varied in Ca concentration. Within each type of protein, Ca concentrations of 0.67% [low Ca (LC)] or 2.4% (HC) were chosen, because 0.67% Ca is the naturally occurring concentration of Ca in the SMP diets and 2.4% Ca has been shown to be efficacious in previous weight control studies (15) . Substitution of CaCO 3 for cornstarch increased the Ca content of the diets (16) . All diets were controlled for vitamin D content, because the casein, whey, SPI, and SMP were not fortified and did not contain substantially different amounts. Free access to water was available throughout the experiment. Ad libitum food intake for the control group was measured daily by weighing each food cup to the nearest 0.1 g and then subtracting this weight from the previously measured weight. All spillage was collected from the bottom of the cages and accounted for. ER rats were provided with 70% of the ad libitum food intake of the reference group for 4 wk.
Body weight and composition. Body weight of all rats was measured prior to the ER period and subsequently once per week. Two days prior to the meal tolerance test (MTT), rats were lightly anesthetized and body composition and bone mineral density measured via dual energy X-ray absorptiometry with software for small animal analysis (Hologic QDR 4500, Hologic).
MTT. Following 12 h of food deprivation, rats were anesthetized with isoflurane and a baseline blood sample was collected. Rats were then allowed to wake and were given an oral gavage of their respective diet (4g of diet/kg body weight) emulsified in water to a total volume of 3 mL. Hepatic triglyceride and cholesterol concentrations. Triglyceride (TG) and cholesterol concentrations in liver samples were measured as previously described (19) .
Hepatic gene expression. Total RNA was extracted from the liver using Trizol Reagent (Invitrogen). RNA was quantified using Ribogreen and RT performed using the Omniscript RT kit (Qiagen). Real-time PCR analysis was performed in triplicate using a Bio-Rad Thermal iCycler (Bio-Rad). Glyceraldehyde-3-phosphate (GAPDH) was used as the housekeeping gene and data analyzed using the 2 2DCt method (20) . Genes of interests included: fatty acid synthase (FAS), glucokinase (GK), PPARg co-activator 1 a (PGC1a), PPARg, phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (G6Pase). Primers used for real-time PCR are presented in the 59 to 39 direction, with the forward primer followed by the reverse primer and include: GAPDH: CAAGTTCAACGGCACAGTCAAG and ACATACTCAGCACCAGC-ATCAC; FAS: GAGGACTTGGGTGCCGATTAC and GCTGTGGAT-GATGTTGATGATAGAC; GK: CCGAGTGGCTTACAGTTCTG and ACCTGAGTGTTGGAGATGATTC; PGC 1a: AGAGGCAGAAGCA-GAAAGC and TGTCTCCATCATCCCGCAG; PPARg: ATGTCTCA-CAATGCCATCAGG and CCAGGGCTCGCAGATCAG; PEPCK: CGTGGCTGAGACAAGTGATGG and ACGGTTCCTCATCCTGTG-GTC; and G6Pase: GCTGGAGTCTTGTCAGGCATTG and AGTGC-GAAACCAAACAGGAAGAAG.
Statistics. Data in the text are mean 6 SD. The reference group was excluded from all statistical analysis. Two-way ANOVA was used to determine the main effects of Ca (HC or LC) and protein (casein, SPI, whey, or SMP) and their interaction. We used Tukey's test to identify which means differed when a significant effect was found. Differences were considered significant when P , 0.05. When main effects of calcium or protein were found and there was no significant interaction effect, data were pooled (by protein type or calcium concentration) and post hoc pairwise analysis was performed. When a significant interaction effect was found, differences between all diets were determined using Tukey's test. Levene's test was used to test the assumption of equal variance among the groups. When unequal variance was identified, Tamhane's T2 post hoc test was performed. Weekly body weight and the time course of each hormone and glucose during the MTT were analyzed by 2-way repeated-measures ANOVA followed by Tukey's post hoc test. HOMA-IR and total area under the curve (AUC) were calculated according to previous work (21, 22) .
Results

Food intake
By design, ER rats were provided with and consumed 70% of the food eaten by the reference rats. Over the 4-wk period, reference rats ate 29.
Body weight
Initial body weight and both initial and final crown to rump lengths did not differ among the groups (data not shown). The change in body weight from wk 1 through wk 4 was affected by the interaction of protein source with time (P , 0.0001) and the interaction of dietary Ca with time (P , 0.0001) (Fig. 1). The interaction between the level of Ca and protein source influenced final body weight (P = 0.027), with the whey-LC group having a lower final body weight than the SPI-LC group (P , 0.05) ( Table  2 ). The interaction between Ca and protein also affected body weight loss (P = 0.035) ( Table 2 ). Rats fed whey-LC and -HC and SMP-HC had a greater decline in body weight than those fed SPI-LC (P , 0.05).
Body composition
Both protein (P = 0.028) and Ca (P = 0.006) affected percent body fat (Table 2) , with rats fed SMP having lower body fat (16.5 6 1.6%) than those fed casein (20.2 6 0.9%). Percent body fat in rats fed SPI and whey (19.7 6 1.2 and 17.6 6 0.4%, respectively) did not differ from those fed SMP and casein. Rats fed HC had lower percent fat than those fed LC (17.6 6 0.7 and 20.3 6 0.9%, respectively). The interaction between dietary Ca and protein affected absolute fat mass (FM) (P = 0.027), with rats fed SMP-HC having lower FM than those fed casein-LC or SPI-LC. Lean body mass (LBM) was influenced by protein (P = 0.03) but not Ca (P = 0.12). Rats fed SMP had greater LBM than those fed whey (P = 0.028) (Fig. 2) . LBM in rats fed SPI and casein did not differ from those fed whey or SMP (P . 0.05).
MTT Whole blood glucose. Dietary protein affected (P = 0.001) baseline blood glucose concentration in feed-deprived rats ( Table 3) . Rats fed casein had higher baseline blood glucose concentrations (5.9 6 1.2 mmol/L) than those fed SPI (4.7 6 0.9 mmol/L) or whey (4.6 6 0.7 mmol/L) (P , 0.05); rats fed SMP (4.9 6 1.1 mmol/L) were not different from any other protein group (P . 0.05). Glucose responses at individual time points during the MTT were not significantly different among the ER FIGURE 1 Body weight of rats during 4 wk of energy restriction in male, DIO rats fed casein, SPI, whey, or SMP diets containing LC or HC concentrations. Results are mean 6 SEM, n = 8. Two-way repeated-measures ANOVA revealed a time 3 protein interaction (P = 0.0001) and a time 3 Ca interaction (P = 0.001).
groups (data not shown). Both dietary protein (P = 0.01) and Ca (P = 0.014) affected the total blood glucose AUC during the MTT (P , 0.05) ( Table 3 ). Rats fed SMP had greater glucose AUC than those fed casein (1.5 6 0.4 and 1.0 6 0.3 mol/L 3 90 min, respectively) (P , 0.05); SPI-and whey-fed rats did not differ from those fed SMP or casein (1.2 6 0.5 and 1.1 6 0.4 mol/L 3 90 min, respectively) (P . 0.05). Rats fed LC had greater total glucose AUC than those fed HC (1.3 6 0.4 and 1.1 6 0.5 mol/L 3 90 min, respectively) (P , 0.05).
Plasma insulin. Dietary protein affected baseline plasma insulin concentrations (P , 0.001) and the total insulin AUC after the MTT (P = 0.012) ( Table 3 ). In rats fed SMP, baseline insulin concentrations were less than in those fed casein (103.5 6 52.7 and 166.4 6 54.6 pmol/L, respectively) and SPI (226.7 6 72.4 pmol/L) (P , 0.05); rats fed whey did not differ from those fed casein, SMP, or SPI (140.5 6 32.7 pmol/L) (P . 0.05). Total insulin AUC was lower in SMP-fed rats compared with those fed casein (11.4 6 3.4 and 14.6 6 1.7 nmol/L 3 90 min, respectively) (P , 0.05). In whey and SPI-fed rats, insulin AUC values were intermediate and not different from those fed SMP or casein (12.3 6 3.0 and 12.2 6 3.3 nmol/L 3 90min, respectively) (P . 0.05).
Plasma glucagon. Dietary protein affected (P , 0.001) baseline glucagon concentrations (Table 3) . Rats fed SMP and whey had significantly lower baseline glucagon concentrations (15.9 6 10.6 and 13.5 6 6.5 pmol/L, respectively) than those fed casein or SPI (36.1 6 21.9 and 27.4 6 12.0 pmol/L, respectively). Dietary Ca also independently affected the total glucagon AUC; rats fed HC had lower values than those fed LC (1.3 6 0.6 and 2.1 6 0.9 nmol/L 3 90min, respectively) (P = 0.001).
Plasma ghrelin, leptin, amylin, and GLP-1. Satiety hormone concentrations did not differ at baseline or during the MTT in all ER rats (n = 64). Baseline values were 18.8 6 0.9 GLP-1, 14.0 6 4.3 ghrelin, 5.7 6 0.8 amylin, and 581.7 6 239.1 pmol/L leptin.
HOMA-IR. Both protein (P = 0.001) and dietary Ca (P = 0.04) affected HOMA-IR (Table 3) . Rats fed casein and SPI had HOMA-IR scores that were higher (4.2 6 1.4 and 4.9 6 2.3, respectively) than those fed whey and SMP (2.9 6 0.9 and 2.2 6 1.2, respectively) (P , 0.05). Rats fed HC had higher HOMA-IR than those fed LC (4.0 6 2.0 and 3.2 6 1.5, respectively) (P , 0.05).
Liver TG and cholesterol. Dietary protein affected hepatic TG concentration; rats fed SMP (0.37 6 0.08 mmol/g wet liver weight) had lower concentrations than those fed whey (0.87 6 0.11 mmol/g wet liver weight) (P = 0.007). Casein-and SPI-fed rats had intermediate (0.60 6 0.14 and 0.51 6 0.11 mmol/g wet liver weight, respectively) concentrations. There was no effect of dietary Ca on TG and no effect of protein or Ca on the liver cholesterol concentration.
Liver gene expression. Dietary protein affected hepatic FAS and PGC1a gene expression with greater mRNA levels in rats fed SPI compared with those fed casein, SMP, or whey (P , 0.05) ( Table 4) . Dietary Ca affected G6Pase gene expression, with lower mRNA levels in rats fed HC compared with those fed LC (P , 0.05). The interaction between dietary protein and Ca affected the mRNA levels of PPARg, PEPCK, and GK (Table 4) . PPARg was upregulated in rats fed soy-HC compared with all other diet groups (P , 0.05). PEPCK expression was greater in rats fed SMP-LC and SPI-LC than in those fed casein-LC, whey-LC, and -HC (P , 0.05). GK expression was upregulated in rats 1 Results are mean 6 SD, n = 8. Superscripts are presented only when a significant interaction between protein and Ca was identified. Means without a common letter differ, P , 0.05. 2 The reference group was excluded from statistical analysis. 3 Main effect of protein.
FIGURE 2 LBM after 4 wk of energy restriction in male, DIO rats fed casein, SPI, whey, or SMP diets containing LC or HC concentrations. Results are mean 6 SD, n = 16. Means without a common letter differ, P , 0.05.
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fed casein-LC compared with all other groups except those fed whey-LC (P , 0.05).
Discussion
In this study evaluating the effect of protein (casein, SPI, whey, and SMP) and Ca on weight loss during energy restriction, we demonstrated that: 1) rats fed a high-Ca, SMP diet have lower FM than rats fed a low-Ca, casein, or SPI diet; 2) consumption of SMP during energy restriction preserves LBM more so than whey protein; and 3) glycemic control is inconsistently affected by a diet rich in SMP.
Our first major finding is that the interaction of protein type and dietary Ca affect final body weight, weight loss, and final FM ( Table 2) . While rats fed whey-LC and -HC and SMP-HC had greater weight loss than those fed SPI-LC, only the rats fed SMP-HC had lower FM than those fed SPI-LC and casein-LC. LBM following the 4 wk of energy restriction was also greater in rats fed SMP than those fed whey. Consistent with literature suggesting that Ca found in dairy foods enhances its weight regulatory effect, the effects of protein source in our work are linked to the level of dietary Ca (10) .
Several factors found in dairy products have been suggested to regulate body composition. These include the AA composi- 1 Results are mean 6 SD, n = 8. Superscripts are presented only when a significant interaction between protein and Ca was identified. Means without a common letter differ, P , 0.05. 2 The reference group was excluded from statistical analysis. 3 Main effect of protein. 4 Glucose AUC is expressed as mol/L390 min to fit into the table. Results are mean 6 SD, n = 8. Superscripts are presented only when a significant interaction between protein and Ca was identified.
Means without a common letter differ, P , 0.05. 2 Main effects of protein.
tion, micronutrients such as vitamin D, Ca, or phosphorus, various other immunoproteins, and lactose (1). Our diets were matched for vitamin D levels and Ca, therefore suggesting that a protein-linked factor or one of the other bioactive ingredients found in dairy products is likely the contributing factor. Milk protein is a high quality protein consisting of 80% casein and 20% whey. Of relevance to our study are the digestive properties of casein (slow protein) and whey (fast protein). Because milk protein is a combination of slow and fast proteins, it is plausible that as milk protein digests, casein coagulates in the stomach, resulting in slower transit time, which in turn allows for altered absorption of the whey fraction and its respective bioactive components. This may result in increased intestinal absorption or altered rate of appearance of 1 or more critical AA from the SMP (23) . Milk protein is a rich source of the branched-chain AA (BCAA): leucine, isoleucine, and valine. The BCAA are thought to play an important role in the maintenance of LBM (24) . Dietary leucine has been shown to improve body composition in rats that consume leucine in their drinking water (25) . Similarly, our data showed significant maintenance of LBM with energy restriction in the rats fed SMP ( Table 2 ). The percent energy of leucine in our diets was 1.7, 1.2, 1.1, and 0.8%, respectively, for whey, SMP, casein, and SPI. Although the SMP diet contained a lower percentage of BCAA than whey alone, the unique digestive properties of the whey and casein fractions consumed together as complete milk protein may influence luminal and/or plasma AA concentrations and profiles. Given the knowledge that consumption of various proteins in humans results in distinct postprandial plasma AA profiles (26), future work on the role of leucine and the absorption of the BCAA from dairy products is warranted. Energy restriction is an effective means of inducing weight loss; however, the loss of LBM along with the desired loss of FM is detrimental in terms of preserving metabolically active tissue in the body and impedes weight maintenance (27) . Whereas isolated dairy ingredients, such as lactose, have been shown to reduce FM in rats (28) , the preservation of LBM seen in rats fed SMP compared with whey in this study suggests that the partitioning of nutrients toward LBM and away from FM could be enhanced. The benefits of maintaining LBM during energy restriction may assist with weight maintenance and/or ongoing weight loss (29) .
Several other mechanisms have been proposed to explain the enhanced weight loss with diets rich in dairy products or dietary Ca. These include satiety hormone regulation, increased fecal fat excretion, modulation of intracellular Ca levels, and increased thermogenesis via upregulation of uncoupling protein 2 (10, 30) . We found no differences in the appetite hormones, amylin, ghrelin, or GLP-1, in this study. This is in contrast to studies that show differential satiety hormone response among whey, soy protein, and/or casein-rich diets (26) . A potential explanation for the lack of change in our study could be the normal protein content (12% of energy) of our diets. Many studies demonstrating a difference in satiety hormone response have used highprotein meals or diets with a distinct dose-dependent effect of protein evident on hormone secretion (26, 31) .
Although the role of fecal fat loss via binding to Ca is one mechanism that is gaining popularity in the dietary Ca and weight control debate (32) , the weight loss in our study is greater than can be attributed solely to this intestinal loss of energy. It is plausible, however, that it is one contributing factor given that dietary Ca interacted with protein to significantly affect absolute FM in this study (Table 2 ). An increase in adipocyte uncoupling protein 2 and a change in intracellular Ca levels (30) also cannot be ruled out as potential mechanisms of action as they were not measured in this study.
Our third major finding is that the dietary source of protein alters glucose homeostasis, including glucose, insulin, and glucagon levels, and HOMA-IR. Baseline blood glucose was significantly higher in rats fed casein than in those fed SPI and whey; however, total AUC for the casein group was lower than for the SMP group. The largest glucose AUC occurred in rats fed the SMP diet, even though baseline insulin and glucagon, and HOMA-IR for SMP would suggest improved glucose homeostasis. Postprandial insulin response was also reduced in rats fed the SMP diet. A more direct measurement of insulin sensitivity, such as a euglycemic-hyperinsulinemic clamp, is warranted to further examine how the interaction of protein and Ca affect whole-body glucose homeostasis.
Rats fed SMP and whey had lower HOMA-IR scores than those fed casein and SPI, suggesting improved insulin sensitivity with SMP and whey. This observation supports 2 recent large epidemiological studies where dairy product intake was positively linked to insulin sensitivity (33, 34) . Furthermore, data from our laboratory evaluating the prevention of weight gain (11) showed similar improvement in insulin sensitivity when rats were fed a SMP diet compared with casein or whey diets. In addition to lower FM in the SMP-HC group compared with the casein-LC and soy-LC groups, hepatic TG concentration was also reduced following SMP consumption, which may contribute to improved insulin sensitivity. Wat et al. (35) demonstrated that hepatic steatosis was reduced in mice fed a high-fat diet when it was enriched with dairy milk extract. Consistent with these findings was the greater expression of hepatic FAS and PPARg in our SPI group compared with the groups fed dairyderived proteins (Table 4) . FAS and PPARg are both upregulated in obesity and contribute to declines in insulin sensitivity (36) .
While protein did not affect glucagon AUC, consumption of the HC diets reduced postprandial glucagon responses more than consumption of the LC diets. Secretion of glucagon by the }-cells of the pancreas is critical for glucose homeostasis. In diabetes, an excess of glucagon relative to insulin appears to be partially responsible for hyperglycemia. Hepatic glucose output is elevated in part due to a lack of suppression of glucagon during hyperglycemia [reviewed in (37) ]. We are not aware of any study to date that has found regulation of glucagon by dietary Ca; however, other cations such as zinc are known to play a role in glucagon secretion (38) . It is plausible that an increase in dietary Ca could regulate pancreatic }-cell function; this requires more thorough examination. Glucagon promotes glycogenolysis in the liver, which in turn increases blood glucose. G6Pase is an enzyme that is critical for regulation of this pathway and is positively regulated by glucagon levels. Hepatic gene expression of G6Pase was reduced in the HC group, which is consistent with our finding of lower plasma glucagon in rats fed HC compared with LC concentrations. However, it is not known whether it was glucagon per se or the direct effect of Ca that altered the expression of this gene. Numerous pharmacological treatments for diabetes (imidazolines, GLP-1, GLP-1 mimetics, and DPP4 inhibitors) either indirectly or directly stimulate insulin and inhibit glucagon secretion (39) (40) (41) .
The data regarding glucose homeostasis and insulin sensitivity is not consistent among groups in this study. There are factors that would suggest that SMP improves insulin sensitivity (HOMA-IR), yet other measures (total glucose AUC) contradict this. Additionally, the difference between the 2 dietary Ca concentrations also corroborates this, as the greater HOMA-IR in rats fed HC is not consistent with their AUC and body Dairy components and weight loss 1239 composition data. The disparity in this data may be due to the differential effects of protein source and Ca on hepatic gene expression. For example, the interaction between dietary protein and Ca affected PPARg, PEPCK, and GK mRNA levels, whereas only protein source affected FAS and PGC1a mRNA levels, and only Ca affected G6Pase mRNA levels (Table 4) .
PGC1a, PEPCK, GK, and G6Pase are all key factors in the regulation of glucose homeostasis, with PGC1a, PEPCK, and G6Pase downregulating glycolysis and glycogenesis and upregulating gluconeogenesis; GK does the opposite (42) . Our data demonstrates that dietary protein source and Ca concentration differentially regulate the expression of these genes, which may account for apparently opposing and inconsistent outcomes in glucose homeostasis. Further examination of dietary factors that regulate hepatic genes related to glucose metabolism is warranted to fully determine the benefits and/or risks to glycemic control associated with the combined intake of SMP and high dietary Ca. Future work should also focus on the role of particular AA in regulating hepatic genes related to glucose and lipid metabolism and direct measurements of portal and systemic AA concentrations Because SMP has a lower protein concentration than the other proteins used in this study, we had to use a greater amount to achieve 12% protein energy in all diets (i.e. 345 vs. 140 g/kg) ( Table 1 ). This invariably increased the intake of numerous bioactive ingredients by rats fed the SMP diet compared with the other diets, which cannot be strictly controlled for. This is a limitation of the study and highlights the complex nature of SMP. Use of complete milk protein precipitated from SMP would control for differences in lactose and other compounds associated with SMP but would limit the investigation of the global effects of SMP-rich diets, which was our primary focus.
In conclusion, many studies to date have examined the role of dairy foods in body weight regulation; this is the first study, to our knowledge, to provide a direct comparison of casein, whey, SPI, and SMP proteins with HC or LC concentrations on weight loss during energy restriction. We showed that LBM was preserved to a greater extent in rats fed SMP than in those fed whey but not more so than the other diets tested (casein and SPI). Furthermore, the significantly lower FM in rats fed the SMP-HC diet compared with SPI-LC and casein-LC diets did not consistently reflect changes in HOMA-IR among the groups. Although SMP appears to have beneficial effects on body composition during energy restriction, these effects are not consistently identified against any one of the other protein sources examined. Similarly, the changes in glucose AUC and HOMA-IR are inconsistent and do not provide convincing evidence for the direction of change in glucose control in these rats. Future studies with robust measures of insulin sensitivity are needed that examine additional bioactive compounds found in dairy food, as our data suggest that neither casein nor whey alone match the metabolic changes observed with SMP.
